What did the placebo arm of SOUL report for dizziness?

Asked 9 Oct 2025Modified 10 months agoViewed 6.8k times

What I am working with: SOUL · dizziness.

I would like help reading this properly rather than being told what conclusion to reach.

I have the full report including the method section, so I can quote specifics if that helps.

How should I read this, and where are the traps?

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questionsgi-side-effects

gi-side-effects

The gastrointestinal cluster as a whole - nausea, vomiting, diarrhoea, constipation, reflux, early satiety - with trial incidence rates, dropout…

416 questionsnausea

nausea

The dominant tolerability signal in every trial of the class: incidence, timing relative to a dose step, duration, and the distinction between…

346 questions

shareeditfollowflag

askedharriet_lonsdale14k279 Oct 2025

6I would gently push back on the second point — the evidence there is thinner than stated. – h_pergande 5 months ago

7Adding for future readers: the certificate should carry the lot number, not just a batch code. – s_kalniete 6 months ago

add a comment

No answers yet

This question has not been answered. It has been viewed 6.8k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.

Linked questions

21 Does hair thinning at week four of survodutide usually resolve without a dose change?23 Does holding at 20 mg for two weeks before escalating reduce headache?25 What is the reported incidence of hair thinning on tirzepatide in STEP 3?27 What is the reported incidence of nausea on tirzepatide in SURMOUNT-2?

PeptideMeter

Published, aggregated third-party test data and vendor ratings. Stated methodology.

Browse results

Hot on the stack

If I reconstitute a 2.5 mg vial with 5 mL of 0.9% sodium chloride, what concentration do I end up with?25 votes · 5 answers · 42k views What does STEP 3 actually establish about survodutide?30 votes · 5 answers · 43k views How do I photograph a vial so someone can actually assess it?34 votes · 5 answers · 67k views Is STEP 4 a fair comparison of mazdutide against its comparator arm?34 votes · 5 answers · 71k views What does peptide mapping add for semaglutide that a purity figure does not?26 votes · 5 answers · 45k views How many vials from a JEEP lot should I send for a Karl Fischer water content test?26 votes · 5 answers · 46k views What does the mechanism of oral semaglutide predict that SURMOUNT-1 did not test?35 votes · 5 answers · 44k views

The stack

Questions5.2k

Answers20k

Accepted3.1k

Unanswered741

Tags107

Users220

Vendors tracked20

What did the placebo arm of SOUL report for dizziness?

clinical-trials

gi-side-effects

nausea

No answers yet

PeptideMeter - Independent Peptide Analytics

Your answer

Browse

About